Hocking J - Search Results

1

Fludarabine, cytarabine, granulocyte-colony stimulating factor and amsacrine: an effective salvage therapy option for acute myeloid leukemia at first relapse.

Fong CY, Grigoriadis G, Hocking J, Coutsouvelis J, Muirhead J, Campbell P, Paul E, Walker P, Avery S, Patil S, Spencer A, Schwarer A, Wei A. Fong CY, et al. Among authors: hocking j. Leuk Lymphoma. 2013 Feb;54(2):336-41. doi: 10.3109/10428194.2012.713479. Epub 2012 Sep 8. Leuk Lymphoma. 2013. PMID: 22812445

2

Excellent outcomes for adolescents and adults with acute lymphoblastic leukemia and lymphoma without allogeneic stem cell transplant: the FRALLE-93 pediatric protocol.

Hocking J, Schwarer AP, Gasiorowski R, Patil S, Avery S, Gibson J, Iland H, Ho PJ, Joshua D, Muirhead J, Lai H, Irving I. Hocking J, et al. Leuk Lymphoma. 2014 Dec;55(12):2801-7. doi: 10.3109/10428194.2014.894191. Epub 2014 Mar 19. Leuk Lymphoma. 2014. PMID: 24528220 Clinical Trial.

3

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies.

Hocking J, Mithraprabhu S, Kalff A, Spencer A. Hocking J, et al. Cancer Biol Med. 2016 Jun;13(2):215-25. doi: 10.20892/j.issn.2095-3941.2016.0025. Cancer Biol Med. 2016. PMID: 27458529 Free PMC article.

4

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma.

Mithraprabhu S, Khong T, Ramachandran M, Chow A, Klarica D, Mai L, Walsh S, Broemeling D, Marziali A, Wiggin M, Hocking J, Kalff A, Durie B, Spencer A. Mithraprabhu S, et al. Among authors: hocking j. Leukemia. 2017 Aug;31(8):1695-1705. doi: 10.1038/leu.2016.366. Epub 2016 Nov 30. Leukemia. 2017. PMID: 27899805

5

Adverse impact of high donor CD3+ cell dose on outcome following tandem auto-NMA allogeneic transplantation for high-risk myeloma.

Nair AP, Walker P, Kalff A, Bergin K, Hocking J, Avery S, Curtis DJ, Patil S, Das T, Klarica D, Morgan S, Muirhead J, Gorniak M, Reynolds J, Spencer A. Nair AP, et al. Among authors: hocking j. Bone Marrow Transplant. 2017 Jun;52(6):839-845. doi: 10.1038/bmt.2017.37. Epub 2017 Mar 20. Bone Marrow Transplant. 2017. PMID: 28319080

6

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients.

Mithraprabhu S, Morley R, Khong T, Kalff A, Bergin K, Hocking J, Savvidou I, Bowen KM, Ramachandran M, Choi K, Wong BKL, Reynolds J, Spencer A. Mithraprabhu S, et al. Among authors: hocking j. Leukemia. 2019 Aug;33(8):2022-2033. doi: 10.1038/s41375-019-0469-x. Epub 2019 Apr 16. Leukemia. 2019. PMID: 30992504

7

DNA-Repair Gene Mutations Are Highly Prevalent in Circulating Tumour DNA from Multiple Myeloma Patients.

Mithraprabhu S, Hocking J, Ramachandran M, Choi K, Klarica D, Khong T, Reynolds J, Spencer A. Mithraprabhu S, et al. Among authors: hocking j. Cancers (Basel). 2019 Jun 29;11(7):917. doi: 10.3390/cancers11070917. Cancers (Basel). 2019. PMID: 31261969 Free PMC article.

8

TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing.

Reale A, Khong T, Mithraprabhu S, Savvidou I, Hocking J, Bergin K, Ramachandran M, Chen M, Dammacco F, Ria R, Silvestris F, Vacca A, Reynolds J, Spencer A. Reale A, et al. Among authors: hocking j. Leuk Lymphoma. 2021 Feb;62(2):337-347. doi: 10.1080/10428194.2020.1832659. Epub 2020 Oct 31. Leuk Lymphoma. 2021. PMID: 33131357

9

Receiving four or fewer cycles of therapy predicts poor survival in newly diagnosed transplant-ineligible patients with myeloma who are treated with bortezomib-based induction.

Boyle S, Wellard C, Moore EM, Blacklock H, Harrison SJ, Ho PJ, Hocking J, McQuilten ZK, Quach H, Spearing R, Wood EM, Spencer A, Mollee P; Myeloma and Related Diseases Registry investigators. Boyle S, et al. Among authors: hocking j. Eur J Haematol. 2021 Oct;107(4):497-499. doi: 10.1111/ejh.13677. Epub 2021 Jun 26. Eur J Haematol. 2021. PMID: 34129711 No abstract available.

10

The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma.

Rees MJ, Panigrahi A, Harrison SJ, Spencer A, Khong T, Gibbs S, Hocking J, Grigg A, Zantomio D. Rees MJ, et al. Among authors: hocking j. Bone Marrow Transplant. 2022 Jun;57(6):1001-1003. doi: 10.1038/s41409-022-01647-0. Epub 2022 Mar 28. Bone Marrow Transplant. 2022. PMID: 35352035 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

609 results

Search Page

Filters